Analysis of the pathological lesions of the lung in a mouse model of cutaneous infection with Streptococcus pyogenes

Pathology International

Volumn 62, Issue 2, 2012, Pages 99-104

  Minami, Masaaki ^a   Sobue, Sayaka ^b   Ichihara, Masatoshi ^b   Hasegawa, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b CHUBU UNIVERSITY   (Japan)

Author keywords

CT; Histopathology; Lung; Mouse infection model; Streptococcus pyogenes; STSS

Indexed keywords

CYTOKERATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LUNG; LUNG LESION; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; SKIN INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; LUNG; MICE; SKIN; SKIN DISEASES, INFECTIOUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84855979848     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2011.02756.x     Document Type: Article

References (50)

1. Cone LA, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317: 146-9.
2. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
3. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29: 1562-7.
4. Reichardt W, Muller-Alouf H, Alouf JE, Kohler W. Erythrogenic toxins A, B and C: Occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microbiol Lett 1992; 79: 313-22.
5. Tanaka M, Hasegawa T, Okamoto A, Torii K, Ohta M. Effect of antibiotics on group A Streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis. Antimicrob Agents Chemother 2005; 49: 88-96.
6. Sawai J, Hasegawa T, Kamimura T etal. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother 2007; 51: 461-7.
7. Hasegawa T, Torii K, Hashikawa S, Iinuma Y, Ohta M. Cloning and characterization of the deoxyribonuclease sdα gene from Streptococcus pyogenes. Curr Microbiol 2002; 45: 13-7.
8. Hasegawa T, Torii K, Hashikawa S, Iinuma Y, Ohta M. Cloning and characterization of two novel DNases from Streptococcus pyogenes. Arch Microbiol 2002; 177: 451-6.
9. Nakamura T, Hasegawa T, Torii K, Hasegawa Y, Shimokata K, Ohta M. Two-dimensional gel electrophoresis analysis of the abundance of virulent exoproteins of group A streptococcus caused by environmental changes. Arch Microbiol 2004; 181: 74-81.
10. Bricker AL, Carey VJ, Wessels MR. Role of NADase in virulence in experimental invasive group A streptococcal infection. Infect Immun 2005; 73: 6562-6.
11. Lukomski S, Sreevatsan S, Amberg C etal. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J Clin Invest 1997; 99: 2574-80.
12. Oehmcke S, Shannon O, von Kockritz-Blickwede M etal. Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood 2009; 114: 444-51.
13. Lukomski S, Nakashima K, Abdi I etal. Identification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen. Infect Immun 2000; 68: 6542-53.
14. Ashbaugh CD, Wessels MR. Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun 2001; 69: 6683-8.
15. Fontaine MC, Lee JJ, Kehoe MA. Combined contributions of streptolysin O and streptolysin S to virulence of serotype M5 Streptococcus pyogenes strain Manfredo. Infect Immun 2003; 71: 3857-65.
16. Nyberg P, Sakai T, Cho KH, Caparon MG, Fassler R, Björck L. Interactions with fibronectin attenuate the virulence of Streptococcus pyogenes. EMBO J 2004; 23: 2166-74.
17. Zhu H, Liu M, Sumby P, Lei B. The secreted esterase of group A streptococcus is important for invasive skin infection and dissemination in mice. Infect Immun 2009; 77: 5225-32.
18. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 1998; 102: 550-60.
19. Schrager HM, Rheinwald JG, Wessels MR. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 1996; 98: 1954-8.
20. Lukomski S, Montgomery CA, Rurangirwa J etal. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect Immun 1999; 67: 1779-88.
21. Heath A, DiRita VJ, Barg NL, Engleberg NC. A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 1999; 67: 5298-305.
22. Limbago B, Penumalli V, Weinrick B, Scott JR. Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 2000; 68: 6384-90.
23. Engleberg NC, Heath A, Vardaman K, DiRita VJ. Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes. Infect Immun 2004; 72: 623-8.
24. Husmann LK, Dillehay DL, Jennings VM, Scott JR. Streptococcus pyogenes infection in mice. Microb Pathog 1996; 20: 213-24.
25. Husmann LK, Yung DL, Hollingshead SK, Scott JR. Role of putative virulence factors of Streptococcus pyogenes in mouse models of long-term throat colonization and pneumonia. Infect Immun 1997; 65: 1422-30.
26. Limbago B, McIver KS, Penumalli V, Weinrick B, Scott JR. Restoration of Mga function to a Streptococcus pyogenes strain (M Type 50) that is virulent in mice. Infect Immun 2001; 69: 1215-20.
27. Hasegawa T, Minami M, Okamoto A, Tatsuno I, Isaka M, Ohta M. Characterization of a virulence-associated and cell-wall-located DNase of Streptococcus pyogenes. Microbiology 2010; 156: 184-90.
28. Tatsuno I, Isaka M, Minami M, Hasegawa T. NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates. BMC Microbiol 2010; 10: 144.
29. Greschus S, Kiessling F, Lichy MP etal. Potential applications of flat-panel volumetric CT in morphologic and functional small animal imaging. Neoplasia 2005; 7: 730-40.
30. Hasegawa T, Okamoto A, Kamimura T etal. Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients. APMIS 2010; 118: 167-78.
31. Hashimoto N, Kawabe T, Imaizumi K etal. CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury. Am J Respir Cell Mol Biol 2004; 30: 808-15.
32. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269: 384-9.
33. Vikerfors A, Haggar A, Darenberg J etal. Severe group A streptococcal infections in Uppsala County, Sweden: Clinical and molecular characterization of a case cluster from 2006 to 2007. Scand J Infect Dis 2009; 41: 823-30.
34. Muller MP, Low DE, Green KA etal. Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 2003; 163: 467-72.
35. Ooe K, Nakada H, Udagawa H, Shimizu Y. Severe pulmonary hemorrhage in patients with serious group A streptococcal infections: Report of two cases. Clin Infect Dis 1999; 28: 1317-9.
36. Tajiri T, Tate G, Akita H etal. Autopsy cases of fulminant-type bacterial infection with necrotizing fasciitis: Group A (beta) hemolytic Streptococcus pyogenes versus Vibrio vulnificus infection. Pathol Int 2008; 58: 196-202.
37. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-1996. A 51-year-old man with the adult respiratory distress syndrome. N Engl J Med 1996; 334: 1116-23.
38. Shanley TP, Schrier D, Kapur V, Kehoe M, Musser JM, Ward PA. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 1996; 64: 870-77.
39. Guzman CA, Talay SR, Molinari G, Medina E, Chhatwal GS. Protective immune response against Streptococcus pyogenes in mice after intranasal vaccination with the fibronectin-binding protein SfbI. J Infect Dis 1999; 179: 901-6.
40. Herwald H, Cramer H, Morgelin M etal. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004; 116: 367-79.
41. Pahlman LI, Morgelin M, Eckert J etal. Streptococcal M protein: A multipotent and powerful inducer of inflammation. J Immunol 2006; 177: 1221-8.
42. Soehnlein O, Oehmcke S, Ma X etal. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 2008; 32: 405-12.
43. Zhang S, Rahman M, Zhang S, Qi Z, Herwald H, Thorlacius H. Simvastatin regulates CXC chemokine formation in streptococcal M1 protein-induced neutrophil infiltration in the lung. Am J Physiol Lung Cell Mol Physiol 2011; 300: L930-L939.
44. Tesfaigzi J, Wood MB, Johnson NF, Nikula KJ. Apoptosis is a pathway responsible for the resolution of endotoxin-induced alveolar type II cell hyperplasia in the rat. Int J Exp Pathol 1998; 79: 303-11.
45. Wang HC, Shun CT, Hsu SM, Kuo SH, Luh KT, Yang PC. Fas/Fas ligand pathway is involved in the resolution of type II pneumocyte hyperplasia after acute lung injury: Evidence from a rat model. Crit Care Med 2002; 30: 1528-34.
46. Miller BE, Hook GE. Hypertrophy and hyperplasia of alveolar type II cells in response to silica and other pulmonary toxicants. Environ Health Perspect 1990; 85: 15-23.
47. Amigoni M, Bellani G, Scanziani M etal. Lung injury and recovery in a murine model of unilateral acid aspiration: Functional, biochemical, and morphologic characterization. Anesthesiology 2008; 108: 1037-46.
48. Lopera D, Naranjo T, Hidalgo JM etal. Pulmonary abnormalities in mice with paracoccidioidomycosis: A sequential study comparing high resolution computed tomography and pathologic findings. PLoS Negl Trop Dis 2010; 4: e726.
49. Mason WJ, Skaar EP. Assessing the contribution of heme-iron acquisition to Staphylococcus aureus pneumonia using computed tomography. PLoS ONE 2009; 4: e6668.
50. Armbrust LJ, Mosier DA, Nelson EL, Hart ML, Chapes SK. Correlation of results of pulmonary computed tomography and pathologic findings in mice with Pasteurella-induced pneumonia. Am J Vet Res 2005; 66: 835-8.